U.S. President Donald Trump on Friday hailed a report on economic growth as a sign that the economy was mounting a remarkable turnaround under his stewardship. The facts are more nuanced.
U.S. stock indexes were lower on Friday as weak earnings reports from Intel and Twitter dragged on the technology sector and as healthcare stocks were pressured by a clutch of disappointing earnings.
Intel Corp shares fell 9 percent on Friday, after the chipmaker’s upbeat results were overshadowed by concerns that Advanced Micro Devices Inc may be chiseling off market share from its high-margin data center business.
Bayer AG disputed accusations in a new Netflix documentary that claims medical device makers and the U.S. Food and Drug Administration placed profits before patient safety.
The MoviePass owner is now running its business on IOUs. …read more […]
Shares of U.S. television network CBS Corp tumbled 6.3 percent to $53.88 midday on Friday after the Hollywood Reporter said that the New Yorker magazine would soon publish a claim that CBS chief executive officer Les Moonves has been accused of sexual harassment.
Twitter Inc on Friday said it lost 1 million monthly active users from the previous quarter and warned the closely watched figure could keep falling as it deletes more phony accounts, causing the biggest one-day decline in its shares since 2016.
Colgate-Palmolive Co said on Friday that it would “modestly” raise prices in the second-half of the year, mainly in emerging markets, as the world’s largest toothpaste maker seeks relief from surging raw materials costs. The industry also has been rocked this year by rising commodities and transportation prices. Shares in Colgate were flat on Friday, reversing course from a 3 percent decline after the company reported weaker-than-expected quarterly sales and warned that it expected slower full-year net sales growth. …read more […]
Twenty-First Century Fox Inc and Walt Disney Co said on Friday their shareholders voted to approve Disney’s $71 billion purchase of Fox’s film and television assets.
Merck & Co beat quarterly profit estimates on Friday as sales of its blockbuster drug Keytruda overtook rival Bristol-Myers Squibb’s Opdivo, but that was not enough for investors who expected bigger gains in market share for the cancer therapy.
U.S. stocks fell on Friday as technology shares were dragged lower by disappointing results from Intel and Twitter, although a jump in Amazon after strong earnings helped curb losses.
World shares were little changed on Friday as mixed corporate profits and economic data that met expectations struggled to offset concerns over trade and central bank policy, though a key global equity index was still set for a fourth week of gains.
Exxon Mobil Corp and Chevron Corp, two of the world’s largest oil producers, posted quarterly results far short of Wall Street’s expectations on Friday.
Merck & Co beat quarterly earnings estimates as sales of blockbuster drug Keytruda nearly doubled, but investors were disappointed after the drugmaker said it was unlikely to follow rival Eli Lilly in separating its animal health unit.
From AT&T and Time Warner to the hot pursuit of 21st Century Fox and Sky, media mergers are in full swing. Why now? WSJ’s Amol Sharma answers all your questions about the forces driving media deals. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
